eczema

Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention. Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With...

A new study suggests that some lesser-known cannabinoids in hemp and marijuana can help with common skin conditions like psoriasis, eczema and acne. A study published by the journal 'Molecules' aptly notes, “Dermatological diseases pose a significant burden on the...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma engaged in the development of therapies for unmet need, releases positive early-stage data for its BioLexa platform. What Happened: New York-based Hoth says data from the Cohort 1 of a two-part, Phase 1b study of BioLexa...

Arcutis Biotherapeutics Inc (NASDAQ: ARQT) will terminate the Phase 2a trial evaluating ARQ-252 as a potential treatment for vitiligo.  The study was initiated in March 2021. The decision is based on further analysis of the ARQ-252 drug formulation used in both this...

In a public conference call on Monday, Anacor Pharmaceuticals Inc (NASDAQ: ANAC) executives announced the results of two Phase 3 trials for a topical drug to treat atopic dermatitis, more commonly known as eczema. The treatment came in the form of a topical ointment, crisaborole. Atopic dermatitis...